There are SAM‐uncompetitive inhibitor of PRMT5 (EPZ015666/GSK3326595) that has been shown to be an effective antiproliferative agent in mantle cell lymphoma models with of PRMT5 overexpression [33]. This evidence concerns the gene PRMT5 and mantle cell lymphoma.